These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 28612631

  • 1. Genetically attenuated malaria parasites as vaccines.
    Vaughan AM, Kappe SHI.
    Expert Rev Vaccines; 2017 Aug; 16(8):765-767. PubMed ID: 28612631
    [No Abstract] [Full Text] [Related]

  • 2. The case for a subunit vaccine against malaria.
    Anders RF.
    Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861
    [Abstract] [Full Text] [Related]

  • 3. Preerythrocytic malaria vaccine development.
    Mikolajczak SA, Aly AS, Kappe SH.
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [Abstract] [Full Text] [Related]

  • 4. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A, Barry AE, Dutta S, Remarque EJ, Beeson JG, Plowe CV.
    Vaccine; 2015 Dec 22; 33(52):7506-12. PubMed ID: 26475447
    [Abstract] [Full Text] [Related]

  • 5. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P.
    Front Immunol; 2020 Dec 22; 11():190. PubMed ID: 32153565
    [Abstract] [Full Text] [Related]

  • 6. Live attenuated pre-erythrocytic malaria vaccines.
    Keitany GJ, Vignali M, Wang R.
    Hum Vaccin Immunother; 2014 Dec 22; 10(10):2903-9. PubMed ID: 25483648
    [Abstract] [Full Text] [Related]

  • 7. Malaria vaccine development using synthetic peptides as a technical platform.
    Corradin G, Céspedes N, Verdini A, Kajava AV, Arévalo-Herrera M, Herrera S.
    Adv Immunol; 2012 Dec 22; 114():107-49. PubMed ID: 22449780
    [Abstract] [Full Text] [Related]

  • 8. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
    Annoura T, Ploemen IH, van Schaijk BC, Sajid M, Vos MW, van Gemert GJ, Chevalley-Maurel S, Franke-Fayard BM, Hermsen CC, Gego A, Franetich JF, Mazier D, Hoffman SL, Janse CJ, Sauerwein RW, Khan SM.
    Vaccine; 2012 Mar 30; 30(16):2662-70. PubMed ID: 22342550
    [Abstract] [Full Text] [Related]

  • 9. New candidate vaccine neutralizes all tested strains of malaria parasite.
    Hum Vaccin Immunother; 2012 Feb 30; 8(2):153-4. PubMed ID: 22745944
    [No Abstract] [Full Text] [Related]

  • 10. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
    Atre T, Robinson TM, Savransky T, Dutta S, Epstein JE, Bergmann-Leitner ES.
    Malar J; 2019 May 29; 18(1):186. PubMed ID: 31142328
    [Abstract] [Full Text] [Related]

  • 11. Vaccination With Sporozoites: Models and Correlates of Protection.
    Goh YS, McGuire D, Rénia L.
    Front Immunol; 2019 May 29; 10():1227. PubMed ID: 31231377
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.
    Calvo-Calle JM, Oliveira GA, Nardin EH.
    J Immunol; 2005 Dec 01; 175(11):7575-85. PubMed ID: 16301667
    [Abstract] [Full Text] [Related]

  • 14. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.
    Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, Williams J, de la Vega P, Ware L, Komisar J, Polhemus M, Richie TL, Epstein J, Tamminga C, Chuang I, Richie N, O'Neil M, Heppner DG, Healer J, O'Neill M, Smithers H, Finney OC, Mikolajczak SA, Wang R, Cowman A, Ockenhouse C, Krzych U, Kappe SH.
    Vaccine; 2013 Oct 09; 31(43):4975-83. PubMed ID: 24029408
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Quantification of Plasmodium knowlesi versus Plasmodium falciparum in the rhesus liver: implications for malaria vaccine studies in rhesus models.
    Shears MJ, Seilie AM, Kim Lee Sim B, Hoffman SL, Murphy SC.
    Malar J; 2020 Aug 31; 19(1):313. PubMed ID: 32867784
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of whole sporozoite malaria vaccines.
    Hollingdale MR, Sedegah M.
    Expert Rev Vaccines; 2017 Jan 31; 16(1):45-54. PubMed ID: 27327875
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.
    Kublin JG, Mikolajczak SA, Sack BK, Fishbaugher ME, Seilie A, Shelton L, VonGoedert T, Firat M, Magee S, Fritzen E, Betz W, Kain HS, Dankwa DA, Steel RW, Vaughan AM, Noah Sather D, Murphy SC, Kappe SH.
    Sci Transl Med; 2017 Jan 04; 9(371):. PubMed ID: 28053159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.